V-Square Quantitative Management’s AbbVie ABBV Stock Holding History

V-Square Quantitative Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.68M	Buy	7,740 +447	+6%	+$99.2K	0.18%	95
2025 Q4	$1.67M	Sell	7,293 -3,774	-34%	-$860K	0.17%	90
2025 Q3	$2.56M	Buy	11,067 +1,205	+12%	+$245K	0.43%	46
2025 Q2	$1.83M	Sell	9,862 -349	-3%	-$64.9K	0.25%	78
2025 Q1	$2.14M	Sell	10,211 -903	-8%	-$176K	0.31%	58
2024 Q4	$1.97M	Buy	11,114 +350	+3%	+$64.3K	0.28%	63
2024 Q3	$2.13M	Buy	10,764 +2,167	+25%	+$404K	0.31%	56
2024 Q2	$1.47M	Sell	8,597 -47	-0.5%	-$7.79K	0.24%	72
2024 Q1	$1.57M	Buy	8,644 +7,210	+503%	+$1.24M	0.22%	66
2023 Q4	$222K	Hold	1,434	–	–	0.04%	403
2023 Q3	$214K	Buy	1,434 +1,296	+939%	+$190K	0.09%	285
2023 Q2	$18.6K	Buy	+138	New	+$20.2K	0.01%	378

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

V-Square Quantitative Management's ABBV Position: Q1 2026 in Review

V-Square Quantitative Management increased its AbbVie (ABBV) stake by 6.1% in Q1 2026, buying an estimated $99.2K and bringing the position to 7,740 shares worth $1.68M. The position accounts for 0.18% of the portfolio, ranked #95.

V-Square Quantitative Management first reported a position in ABBV in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.56M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

V-Square Quantitative Management held 7,740 shares of AbbVie worth $1.68M as of Q1 2026.
V-Square Quantitative Management bought 447 AbbVie shares in Q1 2026, an estimated $99.2K.
AbbVie made up 0.18% of V-Square Quantitative Management's portfolio in Q1 2026, its #95 holding.
V-Square Quantitative Management first reported a position in AbbVie in Q2 2023 and has held it in 12 quarters since.
V-Square Quantitative Management's AbbVie position peaked at $2.56M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on V-Square Quantitative Management's 13F filing for Q1 2026, filed 27 Apr 2026.